Fujita Y - Search Results

1

Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.

Fujita Y, Wideman RD, Asadi A, Yang GK, Baker R, Webber T, Zhang T, Wang R, Ao Z, Warnock GL, Kwok YN, Kieffer TJ. Fujita Y, et al. Gastroenterology. 2010 May;138(5):1966-75. doi: 10.1053/j.gastro.2010.01.049. Epub 2010 Feb 4. Gastroenterology. 2010. PMID: 20138041

2

Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells.

Fujita Y, Chui JW, King DS, Zhang T, Seufert J, Pownall S, Cheung AT, Kieffer TJ. Fujita Y, et al. Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E648-57. doi: 10.1152/ajpendo.90440.2008. Epub 2008 Jul 1. Am J Physiol Endocrinol Metab. 2008. PMID: 18593849 Free article.

3

Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo.

Fujita Y, Wideman RD, Speck M, Asadi A, King DS, Webber TD, Haneda M, Kieffer TJ. Fujita Y, et al. Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E473-9. doi: 10.1152/ajpendo.90636.2008. Epub 2008 Dec 23. Am J Physiol Endocrinol Metab. 2009. PMID: 19106249 Free article.

4

Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut.

Fujita Y, Asadi A, Yang GK, Kwok YN, Kieffer TJ. Fujita Y, et al. Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G608-14. doi: 10.1152/ajpgi.00024.2010. Epub 2010 Feb 25. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20185691 Free article.

5

Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.

Mojibian M, Lam AW, Fujita Y, Asadi A, Grassl GA, Dickie P, Tan R, Cheung AT, Kieffer TJ. Mojibian M, et al. Among authors: fujita y. Gastroenterology. 2014 Jul;147(1):162-171.e6. doi: 10.1053/j.gastro.2014.03.020. Epub 2014 Mar 21. Gastroenterology. 2014. PMID: 24662331

6

Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice.

Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Atageldiyeva KK, Takiyama Y, Abiko A, Makino Y, Kieffer TJ, Haneda M. Yanagimachi T, et al. Among authors: fujita y. Diabetologia. 2016 Mar;59(3):533-41. doi: 10.1007/s00125-015-3842-y. Epub 2015 Dec 22. Diabetologia. 2016. PMID: 26693710

7

Insulin-expressing engineered cell lines and primary cells: surrogate β cells from liver, gut, and other sources.

Wideman RD, Fujita Y, Kieffer TJ. Wideman RD, et al. Among authors: fujita y. Curr Opin Organ Transplant. 2007 Feb;12(1):67-72. doi: 10.1097/MOT.0b013e32801145eb. Curr Opin Organ Transplant. 2007. PMID: 27792092

8

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.

Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Sakagami H, Kitsunai H, Takiyama Y, Abiko A, Makino Y, Kieffer TJ, Haneda M. Yanagimachi T, et al. Among authors: fujita y. Mol Metab. 2016 Dec 31;6(2):226-231. doi: 10.1016/j.molmet.2016.12.009. eCollection 2017 Feb. Mol Metab. 2016. PMID: 28180064 Free PMC article.

9

Harnessing the gut to treat diabetes.

Fujita Y, Cheung AT, Kieffer TJ. Fujita Y, et al. Pediatr Diabetes. 2004;5 Suppl 2:57-69. doi: 10.1111/j.1399-543X.2004.00080.x. Pediatr Diabetes. 2004. PMID: 15601375 Review.

10

Cellular reprogramming of human amniotic fluid cells to express insulin.

Gage BK, Riedel MJ, Karanu F, Rezania A, Fujita Y, Webber TD, Baker RK, Wideman RD, Kieffer TJ. Gage BK, et al. Among authors: fujita y. Differentiation. 2010 Sep-Oct;80(2-3):130-9. doi: 10.1016/j.diff.2010.05.007. Epub 2010 Jun 19. Differentiation. 2010. PMID: 20561745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,397 results

Search Page